| |
 |
ARTICLES 
|
|
| Chronic myelogenous leukemia: is aggressive treatment indicated? |
| B Clarkson |
|
JCO Feb 1 1985: 135–139.
[PDF]
|
 |
| Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice? |
| IC Henderson |
|
JCO Feb 1 1985: 140–143.
[PDF]
|
|
|
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study |
| |
SG Taylor, 4th, LA Kalish, JE Olson, F Cummings, JM Bennett, G Falkson, DC Tormey, and PP Carbone |
| |
JCO Feb 1 1985: 144–154.
[Abstract]
[PDF]
|
|
|
Megestrol acetate therapy for advanced breast cancer |
| |
EJ Gregory, SC Cohen, DW Oines, and CH Mims |
| |
JCO Feb 1 1985: 155–160.
[Abstract]
[PDF]
|
|
|
Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump |
| |
KV Shepard, B Levin, RC Karl, J Faintuch, RA DuBrow, M Hagle, RM Cooper, J Beschorner, and D Stablein |
| |
JCO Feb 1 1985: 161–169.
[Abstract]
[PDF]
|
|
|
Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide |
| |
DH Johnson, SN Wolff, JD Hainsworth, LL Porter, WW Grosh, KR Hande, and FA Greco |
| |
JCO Feb 1 1985: 170–175.
[Abstract]
[PDF]
|
|
|
Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer |
| |
HM Dhingra, M Valdivieso, DT Carr, DF Chiuten, P Farha, WK Murphy, G Spitzer, and T Umsawasdi |
| |
JCO Feb 1 1985: 176–183.
[Abstract]
[PDF]
|
|
|
Late intensification in small-cell lung cancer: a phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation |
| |
JP Sculier, J Klastersky, and P Stryckmans |
| |
JCO Feb 1 1985: 184–191.
[Abstract]
[PDF]
|
|
|
Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia |
| |
HM Kantarjian, L Vellekoop, KB McCredie, MJ Keating, J Hester, T Smith, B Barlogie, J Trujillo, and EJ Freireich |
| |
JCO Feb 1 1985: 192–200.
[Abstract]
[PDF]
|
|
|
Unexpectedly severe toxicity from intensive early treatment of childhood lymphoblastic leukemia |
| |
GK Rivera, WE Evans, DK Kalwinsky, J Mirro, J Ochs, LW Dow, M Abromowitch, CH Pui, GV Dahl, and AT Look |
| |
JCO Feb 1 1985: 201–206.
[Abstract]
[PDF]
|
|
|
Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease |
| |
R Zittoun, A Audebert, B Hoerni, A Bernadou, M Krulik, J Rojouan, H Eghbali, H Merle-Beral, Y Parlier, and J Diebold |
| |
JCO Feb 1 1985: 207–214.
[Abstract]
[PDF]
|
|
|
Lung cancer in Hodgkin's disease: association with previous radiotherapy |
| |
AF List, DC Doll, and FA Greco |
| |
JCO Feb 1 1985: 215–221.
[Abstract]
[PDF]
|
|
|
Tamoxifen flare in advanced endometrial carcinoma |
| |
BJ Brooks, Jr and ME Lippman |
| |
JCO Feb 1 1985: 222–223.
[Abstract]
[PDF]
|
|
|
Methylglyoxal-bis(guanylhydrazone) in hormone-resistant adenocarcinoma of the prostate |
| |
HI Scher, A Yagoda, T Ahmed, and RC Watson |
| |
JCO Feb 1 1985: 224–228.
[Abstract]
[PDF]
|
|
|
Acute effects of salmon calcitonin in multiple myeloma: a valuable method for serial evaluation of osteoclastic lesions and disease activity--a prospective study of 125 patients |
| |
R Bataille, C Legendre, and J Sany |
| |
JCO Feb 1 1985: 229–236.
[Abstract]
[PDF]
|
|
|
High-dose cisplatin with sodium thiosulfate protection |
| |
CE Pfeifle, SB Howell, RD Felthouse, TB Woliver, PA Andrews, M Markman, and MP Murphy |
| |
JCO Feb 1 1985: 237–244.
[Abstract]
[PDF]
|
|
|
High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin- induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy |
| |
SB Strum, JE McDermed, and DF Liponi |
| |
JCO Feb 1 1985: 245–251.
[Abstract]
[PDF]
|
|
|
Analysis of treatment results in craniopharyngioma |
| |
BE Amendola, SS Gebarski, and AG Bermudez |
| |
JCO Feb 1 1985: 252–258.
[Abstract]
[PDF]
|
|
| Adjuvant systemic therapy for resectable breast cancer |
| G Bonadonna and P Valagussa |
|
JCO Feb 1 1985: 259–275.
[PDF]
|
|
|
Mitomycin: ten years after approval for marketing |
| |
DC Doll, RB Weiss, and BF Issell |
| |
JCO Feb 1 1985: 276–286.
[Abstract]
[PDF]
|
|
